Glaxo and AstraZeneca agree £146m deal

GlaxoSmithKline has entered into an agreement with AstraZeneca to acquire a number of over-the-counter medicines predominantly sold in Sweden. GSK will acquire AZ Tika, a company owned by AstraZeneca, for some £146 million in cash. AZ Tika’s portfolio of products includes analgesics and decongestants

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses. More by Marc Barber